Medstar Speciality Hospital

Bangalore, Karnataka 560092

0 studies enrolling now · 3 studies all time

What they study most

Breast Neoplasms, Neoplasm Metastasis, Obesity, Overweight, Type 2 Diabetes

Studies at this site

• A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer — Running, not enrolling
• A Study of Orforglipron (LY3502970) in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone — Completed
• A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes — Completed